Nass Valley Gateway Ltd Announces It Will File Its 2019 EOY Audited Financials and 2019 Annual MD&A Reports by July 15th, 2020, and Within the 30-Day Extension Granted by the BCSC

Vancouver, British Columbia - (NewMediaWire) - July 14, 2020 - Nass Valley Gateway Ltd (CSE:NVG) (OTC:NSVGF)(FSE:3NVN)(the “Company”), and its management announces it has continued to work closely with its auditor (Manning Elliott LLP) to remedy the specific requirement of filing its EOY 2019 Financials, MD&A report and all attending certifications, and will file them on July 15th, 2020, within the 30-day extension provided by the BCSC.

Management has satisfied the alternative information guidelines by continuing to publish bi-weekly updates until the filing is completed on July 15th, 2020.

There are no material changes or other items to report at this time.

ABOUT NASS VALLEY GATEWAY LTD. 

Nass Valley Gateway Ltd. (CSE: NVG) (OTC: NSVGF) (FSE: 3NVN)

Nass Valley Gateway LTD (NVG) is a publicly traded company on the CSE in the Life Sciences category. In late 2018, Nass Valley Gateway agreed to merge with Advanced Bioceuticals Limited, a New Jersey LLC focused on the sales and distribution of organic, non-GMO hemp-based, zero THC, CBD products. NVG CBD products will be sold under the "Nass Valley Gardens" brand via retail, wholesale, direct response, and digital sales channels. NVG’s products will target the pain remediation, dermatology, anti-aging, and beauty markets.

We seek Safe Harbor.

Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.

Company: Nass Valley Gateway Ltd.
422 Richards Street, Suite 170
V6B 2Z4 Vancouver
Canada
Phone: 609-651-0032
E-mail: michael.s@nassvalleygateway.com
Internet: www.nassvalleygateway.com.